190 related articles for article (PubMed ID: 21338618)
1. Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARα deterioration.
Takahashi K; Kamijo Y; Hora K; Hashimoto K; Higuchi M; Nakajima T; Ehara T; Shigematsu H; Gonzalez FJ; Aoyama T
Toxicol Appl Pharmacol; 2011 May; 252(3):237-49. PubMed ID: 21338618
[TBL] [Abstract][Full Text] [Related]
2. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
Muroya Y; Ito O
Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan.
Harada M; Kamijo Y; Nakajima T; Hashimoto K; Yamada Y; Shimojo H; Gonzalez FJ; Aoyama T
Clin Sci (Lond); 2016 Nov; 130(21):1969-1981. PubMed ID: 27496805
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of peroxisome proliferator-activated receptor alpha and gamma agonists in renal proximal tubular cell lines.
Giral H; Villa-Bellosta R; Catalán J; Sorribas V
Toxicol In Vitro; 2007 Sep; 21(6):1066-76. PubMed ID: 17521863
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
Zuo N; Zheng X; Liu H; Ma X
Int J Clin Exp Pathol; 2015; 8(9):10653-61. PubMed ID: 26617775
[TBL] [Abstract][Full Text] [Related]
7. Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu KK; Bhatt R; Kaushal GP; Portilla D
Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
[TBL] [Abstract][Full Text] [Related]
8. Effects of the peroxisome proliferator-activated receptor-alpha agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves.
Litherland NB; Bionaz M; Wallace RL; Loor JJ; Drackley JK
J Dairy Sci; 2010 Jun; 93(6):2404-18. PubMed ID: 20494149
[TBL] [Abstract][Full Text] [Related]
9. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
10. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases intestinal carnitine absorption in rats.
Ringseis R; Lüdi S; Hirche F; Eder K
Pharmacol Res; 2008 Jul; 58(1):58-64. PubMed ID: 18620058
[TBL] [Abstract][Full Text] [Related]
11. Effects of clofibrate treatment in laying hens.
König B; Kluge H; Haase K; Brandsch C; Stangl GI; Eder K
Poult Sci; 2007 Jun; 86(6):1187-95. PubMed ID: 17495091
[TBL] [Abstract][Full Text] [Related]
12. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
[TBL] [Abstract][Full Text] [Related]
14. PPARalpha protects proximal tubular cells from acute fatty acid toxicity.
Kamijo Y; Hora K; Kono K; Takahashi K; Higuchi M; Ehara T; Kiyosawa K; Shigematsu H; Gonzalez FJ; Aoyama T
J Am Soc Nephrol; 2007 Dec; 18(12):3089-100. PubMed ID: 17978304
[No Abstract] [Full Text] [Related]
15. Monocarboxylate transporter (MCT)-1 is up-regulated by PPARalpha.
König B; Koch A; Giggel K; Dordschbal B; Eder K; Stangl GI
Biochim Biophys Acta; 2008 Jun; 1780(6):899-904. PubMed ID: 18375207
[TBL] [Abstract][Full Text] [Related]
16. Developmental and tissue-specific involvement of peroxisome proliferator-activated receptor-alpha in the control of mouse uncoupling protein-3 gene expression.
Pedraza N; Rosell M; Villarroya J; Iglesias R; Gonzalez FJ; Solanes G; Villarroya F
Endocrinology; 2006 Oct; 147(10):4695-704. PubMed ID: 16857752
[TBL] [Abstract][Full Text] [Related]
17. Treatment of lactating sows with clofibrate as a synthetic agonist of PPARα does not influence milk fat content and gains of litters.
Gessner DK; Gröne B; Rosenbaum S; Most E; Hillen S; Becker S; Erhardt G; Reiner G; Eder K
BMC Vet Res; 2015 Mar; 11():54. PubMed ID: 25888880
[TBL] [Abstract][Full Text] [Related]
18. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.
Park CW; Kim HW; Ko SH; Chung HW; Lim SW; Yang CW; Chang YS; Sugawara A; Guan Y; Breyer MD
Diabetes; 2006 Apr; 55(4):885-93. PubMed ID: 16567507
[TBL] [Abstract][Full Text] [Related]
19. [The effect of peroxisome proliferator-activated receptor alpha and gamma ligands on free fatty acid-induced INS-1 cell impairment].
Yang LY; Yang YN; Chen ZJ
Zhonghua Nei Ke Za Zhi; 2003 Dec; 42(12):847-50. PubMed ID: 14728875
[TBL] [Abstract][Full Text] [Related]
20. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
